ANDA 40318, held by Duramed Pharms Barr. Meperidine Hydrochloride.
As of Nov 16, 2026, ANDA 40318 (Meperidine Hydrochloride), held by Duramed Pharms Barr, was first approved by FDA on Oct 5, 1999, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 5, 1999 | Original application | Approved |
| Meperidine Hydrochloride50MG · tablet;oral | Meperidine Hydrochloride | Discontinued |
| Meperidine Hydrochloride100MG · tablet;oral | Meperidine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters